A recent study from the Dana-Farber Cancer Institute has proven that stem cell transplants in myelodysplastic syndrome (MDS) patients were equally successful for patients age 71-74 as it was for patients age 60-65. According to Dr. Gregory Abel, an oncologist at Dana-Farber, “This is good evidence that age alone should not limit who should get a [stem cell] transplant for MDS.”
Stem cell treatments promise longer, healthier lives for patients. This study, in demonstrating that regenerative therapies can be applied to patients of all ages, opens the door to new treatments for diseases that predominantly affect patients of advanced age.
Today, preserving your own stem cells is made simple and affordable for families and individuals by banking dental stem cells. To learn how you can preserve your own valuable stem cells to insure access to emerging personalized regenerative treatments, please visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.